Quick answer
This page lists 12 immunotherapy doctors in Hyderabad, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Immunotherapy doctors in Hyderabad, India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Immunotherapy doctors
FeaturedDr. Bharat Vaswani
MBBS, MD, DM, ECMO, MRCP-UK, PDCR
Clinical Director — Medical Oncology & Hematology · Specialty: Medical Oncologist & Hematologist
Yashoda Hospitals, Secunderabad Hyderabad, India26+ Years experience
Why consider this doctor?
- 26+ years of experience in Medical Oncologist & Hematologist
- Clinical Director — Medical Oncology & Hematology, Yashoda Hospitals, Secunderabad, Present
- Senior Consultant Medical Oncologist, SevenStar Hospital, Nagpur
Expertise & Procedures
- Chemotherapy Administration and Management
- Cancer Immunotherapy
- Targeted Molecular Therapy
- Hormone Therapy for Breast Cancer
- Hematological Malignancy Treatment
Medical Oncologist & Hematologist Experience: 26+ YearsHospital Affiliation: Yashoda Hospitals, SecunderabadHospital accreditation: NABH
Dr. Harish Kancharla
DM, MD, MBBS
Consultant — Medical Oncology and Hemato-Oncology · Specialty: Medical Oncologist and Hemato-Oncologist
Yashoda Hospitals Hyderabad, India14+ Years experience
Why consider this doctor?
- 14+ years of experience in Medical Oncologist and Hemato-Oncologist
- Consultant, Medical Oncology and Hemato-Oncology, Yashoda Hospitals, Hyderabad — Present
- Senior Resident/Fellow, Medical Oncology, AIIMS Delhi — 2017–2020
Expertise & Procedures
- Chemotherapy (conventional cytotoxic and targeted agents)
- Cancer immunotherapy and immune checkpoint inhibitor therapy
- Hormone therapy for breast and urogenital cancers
- Bone marrow transplantation and stem cell therapy
- Palliative care and symptom management
Medical Oncologist and Hemato-Oncologist Experience: 14+ YearsHospital Affiliation: Yashoda Hospitals
Dr. Macha Kiran Kumar
MBBS, MD, DM, ECMO, FCR, PDCR
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospitals, Secunderabad Hyderabad, India13+ Years experience
Why consider this doctor?
- 13+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology — Yashoda Hospitals, Secunderabad (Present)
- Consultant, Medical Oncology — Medicover Cancer Institute, Hitec City, Hyderabad
Expertise & Procedures
- Chemotherapy Administration and Management
- Cancer Immunotherapy and Checkpoint Inhibitors
- Targeted Molecular Therapy
- Hormone Therapy for Breast Cancer
- Autologous Stem Cell Transplantation
Medical Oncologist Experience: 13+ YearsHospital Affiliation: Yashoda Hospitals, SecunderabadHospital accreditation: NABH, NABL
Dr. Naidu N. Bethune
MBBS, MD, DM
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospitals, Hi-Tech City Hyderabad, India21+ Years experience
Why consider this doctor?
- 21+ years of experience in Medical Oncologist
- Senior Consultant — Medical Oncology, Yashoda Hospitals, Hi-Tech City, Hyderabad (Present)
- Consultant — Medical Oncology, American Oncology Institute, Hyderabad
Expertise & Procedures
- Chemotherapy Administration for Solid and Hematological Cancers
- Targeted Therapy and Molecular Cancer Treatment
- Cancer Immunotherapy and Checkpoint Inhibitors
- Stem Cell Transplantation
- Bone Marrow Transplantation
Medical Oncologist Experience: 21+ YearsHospital Affiliation: Yashoda Hospitals, Hi-Tech CityHospital accreditation: NABH, NABL
Dr. Nikhil Suresh Ghadyalpatil
MBBS, MD, DM, MNAMS, DNB
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Apollo Hospital, Jubilee Hills Hyderabad, India18+ Years experience
Why consider this doctor?
- 18+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology, Apollo Hospital, Jubilee Hills, Hyderabad — Present
- Specialist in hemato-oncology and translational cancer research across leading Indian oncology centres
Expertise & Procedures
- Chemotherapy Administration for Solid Tumours
- Immunotherapy and Immune Checkpoint Inhibitor Therapy
- Molecular Targeted Therapy Planning
- Hormone Therapy for Breast and Prostate Cancer
- Adjuvant Chemotherapy Management
Medical Oncologist Experience: 18+ YearsHospital Affiliation: Apollo Hospital, Jubilee HillsHospital accreditation: JCI, NABH
Dr. Rekha Bansal
MBBS, DNB, DNB (Medical Oncology), DM (Medical Oncology)
Consultant — Medical Oncology · Specialty: Medical Oncologist
Apollo Hospital, Jubilee Hills Hyderabad, India8+ Years experience
Why consider this doctor?
- 8+ years of experience in Medical Oncologist
- Consultant, Medical Oncology — Apollo Hospital, Jubilee Hills, Hyderabad (Present)
- Over 8 years of clinical experience in oncology and cancer management across tertiary care settings
Expertise & Procedures
- Adjuvant Chemotherapy for Solid Tumors
- Neoadjuvant Chemotherapy Planning
- Palliative Chemotherapy Management
- Immunotherapy with Checkpoint Inhibitors
- Molecular Targeted Therapy
Medical Oncologist Experience: 8+ YearsHospital Affiliation: Apollo Hospital, Jubilee HillsHospital accreditation: JCI, NABH
Dr. Shikhar Kumar
MBBS, MD, DNB, DM, ECMO
Consultant Medical Oncologist · Specialty: Medical Oncologist
Yashoda Hospitals Hyderabad, India13+ Years experience
Why consider this doctor?
- 13+ years of experience in Medical Oncologist
- Consultant Medical Oncologist, Yashoda Hospitals, Hyderabad — Present
- Assistant Professor (Ad-Hoc), Tata Memorial Hospital, Mumbai — 2020–2021
Expertise & Procedures
- Chemotherapy administration and management
- Cancer immunotherapy and checkpoint inhibitor therapy
- Targeted cancer therapy
- Hormone therapy for breast and prostate cancer
- Hematologic malignancy treatment
Medical Oncologist Experience: 13+ YearsHospital Affiliation: Yashoda HospitalsHospital accreditation: NABH, NABL
Dr. Srinivas Chakravarthy G
MBBS, MD (General Medicine), DM Hematology, DM Medical Oncology, American Board Certified in Internal Medicine, American Board Certified in Hematology, American Board Certified in Medical Oncology
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospitals, Secunderabad Hyderabad, India26+ Years experience
Why consider this doctor?
- 26+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology, Yashoda Hospitals, Secunderabad, Hyderabad, India — Present
- Consultant Hematologist and Medical Oncologist, various leading hospitals in Hyderabad and USA — 26+ years
Expertise & Procedures
- Systemic Chemotherapy Administration
- Targeted Molecular Therapy
- Cancer Immunotherapy (CAR-T, Checkpoint Inhibitors)
- Hormone Therapy for Breast and Prostate Cancer
- Hematopoietic Stem Cell Transplantation
Medical Oncologist Experience: 26+ YearsHospital Affiliation: Yashoda Hospitals, SecunderabadHospital accreditation: NABH
Dr. Sudha Sinha
MBBS, American Board Certification in Internal Medicine, American Board Certification in Hematology, American Board Certification in Medical Oncology, ECFMG Certification
Clinical Director, HOD & Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospital Hyderabad, India23+ Years experience
Why consider this doctor?
- 23+ years of experience in Medical Oncologist
- Clinical Director, HOD, and Senior Consultant in Medical Oncology — Yashoda Hospital, Hyderabad, India (Present)
- Consultant Medical Oncologist — Care Hospitals, Hyderabad, India
Expertise & Procedures
- Chemotherapy Administration and Management
- CAR-T Cell Therapy
- Cancer Immunotherapy
- Targeted Therapy for Solid Tumors
- Hormone Therapy for Breast Cancer
Medical Oncologist Experience: 23+ YearsHospital Affiliation: Yashoda Hospital
Dr. Sumanth Kumar Mallupattu
DM, MD, MBBS
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
CARE Hospitals Hyderabad, India14+ Years experience
Why consider this doctor?
- 14+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology — CARE Hospitals, Hyderabad
- Consultant, Haemato-Oncology — Yashoda Hospital, Secunderabad
Expertise & Procedures
- Chemotherapy for Solid Organ Cancers
- Cancer Immunotherapy (ICIs and CAR-T)
- Targeted Therapy and Molecular-Guided Treatment
- Hormone Therapy for Breast Cancer
- Management of Lymphomas and Leukaemias
Medical Oncologist Experience: 14+ YearsHospital Affiliation: CARE Hospitals
Hospitals where these doctors practise
🇮🇳 Hitec City, Hyderabad, IndiaStarting from$1,000
Medicover Hospital Hitec City
Est. 2011
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
3+
Doctors for Immunotherapy
4.3
95 reviews
250+
Beds
15+
Years Since Founded
🇮🇳 Hyderabad, IndiaStarting from$1,000
Apollo Hospitals, Jubilee Hills
Est. 1988
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyMedical OncologyCardiac SurgeryCardiology
4+
Doctors for Immunotherapy
4.1
44 reviews
550+
Beds
38+
Years Since Founded
Why consider treatment in India?
Many international patients consider India for ovarian / gynaecological cancers treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
About the Procedure
What is Immunotherapy?
Immunotherapy uses drugs that help the patient's own immune system recognize and destroy cancer cells, and is used across many cancers including breast, lung, colorectal, gastric/esophageal, liver/pancreatic, ovarian/gynaecological, head & neck cancers, leukemia, lymphoma, and multiple myeloma. It is given as an infusion in cycles, either alone or combined with chemotherapy/targeted therapy, and India offers globally approved immunotherapy drugs and advanced options like CAR-T cell therapy at a fraction of Western costs. Treatment plans are individualized based on tumor type, biomarker status (e.g., PD-L1, MSI), and stage of disease.
Who may be considered?
Immunotherapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Drugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.
3 approaches available for this procedure:
Immune Checkpoint Inhibitor Therapy
Most CommonDrugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.
Comprehensive Investigations
Estimated cost: $400 - $1,500
CBC, liver and kidney function tests, thyroid function tests, PD-L1/MSI/biomarker testing, contrast CT/PET-CT, ECG, tumor board review
Treatment / Procedure Estimate
Estimated cost in India: $1,500 - $3,500 per cycle
Stay in India
Pre-procedure stay (outside hospital): ~2-3 days
Hospitalisation: ~1 day (day-care per cycle)
Recovery period (outside hospital): ~2-3 days recommended between cycles
Total stay: approx 4-6 cycles over 3-6 months
Usually Included in Hospital Package
- Oncologist consultations
- Day-care infusion facility
- Drug administration and monitoring
- Pre-cycle blood work
- Nursing care during infusion
Usually Not Included
- Cost of immunotherapy drug (billed per cycle)
- Interim PET-CT/imaging for response assessment
- Management of immune-related side effects if hospitalization needed
- Genetic/biomarker testing not covered under package
Recovery and follow-up
Most patients tolerate immunotherapy infusions as outpatients and can resume light activity within a day or two, though fatigue, skin rash, or flu-like symptoms are common and are monitored through regular blood tests before each cycle. CAR-T patients require a longer inpatient recovery period with close monitoring for delayed immune reactions.
Risks
Immunotherapy can trigger immune-related side effects affecting the skin, gut, lungs, liver, or endocrine glands, and rarely severe reactions like cytokine release syndrome (especially with CAR-T) that require prompt hospital management. Response to treatment varies by tumor type and biomarker status, and not all patients achieve remission.
Alternatives
Depending on the cancer type and stage, alternatives include conventional chemotherapy, targeted therapy, radiation therapy, hormonal therapy, surgery, or a combination approach as advised by the tumor board.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Histopathology and biopsy report confirming cancer type
- Biomarker/genetic testing results (PD-L1, HER2, MSI, EGFR, etc.)
- Recent CT/PET-CT/MRI imaging reports
- Complete blood count and liver/kidney function tests
- Previous chemotherapy/radiotherapy/surgery records
- Bone marrow biopsy report (for blood cancers)
- Cardiac evaluation report (ECG/ECHO)
- Discharge summaries from previous hospitalizations
Patient information needed
- Current age, weight, and general performance status
- Detailed cancer diagnosis with stage and biomarker status
- History of prior treatments and response to them
- Any known drug allergies or autoimmune conditions
- Current medications including steroids or immunosuppressants
- Presence of other chronic conditions (diabetes, heart or lung disease)
- Availability of a caregiver/attendant during treatment
- Preferred treatment start date and travel flexibility
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Immunotherapy) and procedure (Immunotherapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Immunotherapy in Hyderabad, India
What is Ovarian / Gynaecological Cancers?
Ovarian and gynaecological cancers are malignant tumours arising in the female reproductive system—most commonly the ovaries, uterus, or cervix—that require specialist evaluation to determine their exact type, origin, and extent. Because these cancers differ meaningfully in their biology and behaviour, an accurate diagnosis is the necessary starting point for any discussion of care.
What are the symptoms and health risks of Ovarian / Gynaecological Cancers?
Symptoms can vary widely depending on the organ involved: ovarian cancer may cause persistent bloating, pelvic or abdominal discomfort, early satiety, or urinary changes, while endometrial cancer often presents with abnormal uterine bleeding, and cervical cancer may produce unusual vaginal discharge or post-coital bleeding. Some gynaecological cancers produce few or no early symptoms, which is why unexplained or persistent changes should always be investigated promptly. Symptoms alone are not sufficient to establish a diagnosis, and their absence does not rule out disease.
How is Ovarian / Gynaecological Cancers diagnosed?
Diagnosis typically begins with a detailed personal and family history, a pelvic examination, and targeted imaging such as transvaginal ultrasound, CT, or MRI to assess tumour size, location, and spread. Blood tests—most notably CA-125 for ovarian cancer, as well as HE4 and other markers depending on the suspected cancer type—may support the evaluation, though they are not definitive on their own. Definitive diagnosis and staging (using systems such as the FIGO staging system, which classifies disease from Stage I confined to the organ of origin to Stage IV with distant spread) require histopathological confirmation from a biopsy or surgical specimen.
How is Ovarian / Gynaecological Cancers treated?
Treatment depends on the cancer type, FIGO stage, tumour grade, the patient's overall health, and individual goals of care. Surgery—often performed by a gynaecological oncologist—is a central component for many gynaecological cancers, and is commonly combined with chemotherapy, and in some cases targeted therapy or immunotherapy. For certain early-stage or low-grade tumours, fertility-sparing surgical approaches may be considered, while advanced disease typically requires a multimodal, multidisciplinary treatment plan.
Can Ovarian / Gynaecological Cancers be treated without a procedure?
Medical (non-surgical) therapies play a significant role across all gynaecological cancers. Chemotherapy is commonly used both after surgery (adjuvant) and as a primary treatment when surgery is not immediately possible; targeted therapies such as PARP inhibitors are used in BRCA-associated ovarian cancer; and immunotherapy may be appropriate for certain endometrial and cervical cancers. Hormonal therapy can be a option in specific low-grade endometrial cancers, and radiation therapy is frequently incorporated in cervical cancer management—however, the appropriateness and sequence of each approach depends entirely on individual clinical assessment.
When is Immunotherapy considered for Ovarian / Gynaecological Cancers?
Immunotherapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Ovarian / Gynaecological Cancers?
Gynaecological cancers are primarily evaluated and managed by a gynaecological oncologist, working within a multidisciplinary team that typically includes a medical oncologist for systemic therapies (chemotherapy, targeted therapy, and immunotherapy), a radiation oncologist where radiotherapy is indicated, and specialist radiologists and pathologists. Initial concerns may first be raised by a general gynaecologist or primary care physician who then coordinates the referral.
How do I choose a doctor for Ovarian / Gynaecological Cancers?
When comparing providers, look for a gynaecological oncologist with verifiable experience in your specific cancer type and stage, based at a centre with a formal multidisciplinary tumour board, access to molecular and genetic testing, and a clear plan for ongoing surveillance and follow-up after treatment.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.